DZG Innovation Fund
The DZG Innovation Fund (DZGIF) is a joint research funding program of the German Centers for Health Research. For each round of calls for proposals, there will be an agreed research topic that allows active participation of all DZG. A prerequisite for the funding of a project is the participation of scientists from at least three of the six DZGs.
The aim of the DZGIF is to strengthen networking between its members, to facilitate joint research and thereby create interdisciplinary synergies between the DZGs.
With the establishment of the DZGIF, the centers are pooling their expertise to facilitate and fund promising cross-disease research ideas that advance knowledge on the prevention and treatment of common diseases.
First call: Cell and gene therapy
The topic of the first call was cell and gene therapy. Researchers from five of the six DZGs joined forces and submitted the successful proposal entitled "Cell type-specific targeting for future in vivo delivery in cell & gene therapy." Participating in the project are:
DKTK: Annette Künkele (Berlin), Angela Krackhardt (TUM)
DZD: Gerhard Przemeck, Heiko Lickert (both Helmholtz Munich)
DZHK: Alessandra Moretti (TUM), Johannes Backs (Heidelberg), Oliver J. Müller (Kiel)
DZIF: Tobias Feuchtinger (LMU), Boris Fehse (UKE)
DZL: Nico Lachmann (MHH), Soni Savai Pullamsetti (Giessen)
Second call: Microbiome
Eight full proposals were received by the deadline of 11/30/22 in the second round of calls (topic: microbiome). A total volume of approximately 1.5 million euros is available for the funding of a maximum of two projects.